SIECX Performance — Saratoga International Equity Portfolio, International Equity Class C
Data updated: 2026-07-24
SIECX returned +13.11% year to date and +24.76% over one year to May 2026. Annualised returns are +19.48% over 3 years and +6.42% over 5 years. The fund beat its International Large Growth category average: $100 invested three years ago grew to $171, against $141 for the category, and to $125 over one year, against $114. Volatility over the past three years was 12.90% a year. In the 12 months to May 2026 the fund lost a net $687K, and assets reached $3.54M.
SIECX Growth of $100
What $100 invested in Saratoga International Equity Portfolio grew to, compounded from monthly returns reported on SEC Form N-PORT, against the International Large Growth category average over the same months.
| Period | SIECX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $125 | $114 |
| 3 years (Jun 2023 – May 2026) | $171 | $141 |
| 5 years (Jun 2021 – May 2026) | $137 | $116 |
| Since data start (Mar 2020 – May 2026) | $189 | $170 |
SIECX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +13.11% |
| 1 year | +24.76% |
| 3 years (annualised) | +19.48% |
| 5 years (annualised) | +6.42% |
SIECX Annual Returns
Calendar-year total returns of Saratoga International Equity Portfolio, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +13.11% |
| 2025 | +30.60% |
| 2024 | +4.24% |
| 2023 | +13.64% |
| 2022 | −22.60% |
| 2021 | +18.11% |
| 2020 (Mar–Dec) | +17.87% |
SIECX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +4.1% | +6.3% | −8.4% | +7.8% | +3.5% | — | — | — | — | — | — | — |
| 2025 | +3.3% | +4.3% | +1.5% | +3.2% | +5.0% | +3.2% | −1.0% | +3.9% | +3.1% | −1.8% | +0.4% | +2.2% |
| 2024 | −1.7% | +1.7% | +4.5% | −3.3% | +3.9% | −1.3% | +1.7% | +3.5% | +1.8% | −4.0% | −1.2% | −1.2% |
| 2023 | +10.3% | −3.5% | +1.1% | +0.3% | −5.0% | +4.9% | +5.9% | −3.2% | −3.4% | −4.8% | +5.9% | +5.8% |
| 2022 | −2.9% | −2.1% | −3.3% | −8.5% | +3.7% | −13.2% | +3.1% | −5.2% | −8.6% | +2.9% | +13.8% | −2.3% |
| 2021 | +4.7% | +4.6% | +2.5% | +0.9% | +3.4% | −1.9% | −2.0% | +4.2% | −2.9% | +2.0% | −3.9% | +5.8% |
| 2020 | — | — | −18.1% | +7.5% | +5.3% | +3.3% | +3.4% | +2.3% | −1.7% | −2.7% | +14.7% | +6.1% |
SIECX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 12.90%
- 3-year Sharpe ratio: 1.16 (vs 4.5% risk-free rate)
- Best month: +7.77% (Apr 2026)
- Worst month: −8.36% (Mar 2026)
SIECX Fund Flows
Monthly money in and out of Saratoga International Equity Portfolio, from SEC Form N-PORT.
- 12-month net flow: −$687K
- 12-month gross sales (incl. reinvestments): $613K
- Sales ÷ redemptions: 0.47×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $3K | $129K | −$126K |
| Apr 2026 | $3K | $200K | −$198K |
| Mar 2026 | $5K | $177K | −$172K |
| Feb 2026 | $5K | $28K | −$23K |
| Jan 2026 | $7K | $164K | −$157K |
| Dec 2025 | $454K | $53K | $401K |
| Nov 2025 | $35K | $61K | −$25K |
| Oct 2025 | $935 | $84K | −$83K |
| Sep 2025 | $78K | $68K | $10K |
| Aug 2025 | $6K | $93K | −$87K |
| Jul 2025 | $11K | $94K | −$83K |
| Jun 2025 | $4K | $148K | −$144K |
SIECX Assets Under Management
Net assets of Saratoga International Equity Portfolio by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $3.54M |
| 2026-02-28 | $3.97M |
| 2025-11-30 | $3.27M |
| 2025-08-31 | $3.31M |
| 2025-05-31 | $3.41M |
| 2025-02-28 | $3.29M |
| 2024-11-30 | $3.37M |
| 2024-08-31 | $3.54M |
| 2024-05-31 | $3.45M |
| 2024-02-29 | $3.30M |
| 2023-11-30 | $3.10M |
| 2023-08-31 | $3.45M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.